Latest updates for Experimental Treatment

Fresh curated links around Experimental treatment are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Israeli scientists launch world-first clinical trial for experimental pancreatic cancer treatment
  • Engineered Exosomes as a Treatment for Alzheimer's Disease
  • New treatment approach for children with short-limbed dwarfism

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

jpost.com /1 month ago

Israeli scientists launch world-first clinical trial for experimental pancreatic cancer treatment

The Israeli-developed treatment uses RNA molecules to silence mutated KRAS genes and will be tested alongside standard therapy in patients with locally advanced disease.

Read source
fightaging.org /2 days ago

Engineered Exosomes as a Treatment for Alzheimer's Disease

Exosomes are one category of extracellular vesicle secreted by cells, a membrane-wrapped package of molecules, one complex component of the extensive, incompletely mapped communica...

Read source
medicalxpress.com /5 days ago

New treatment approach for children with short-limbed dwarfism

A phase 3 trial is showing "a potentially giant step forward" in treating children with achondroplasia, UCLA Health's Dr. Isidro B. Salusky wrote in an editorial published in the N...

Read source
virology.ws /2 weeks ago

Trial By Error: Canada’s McMaster University Launches Trial of Lightning Process for Long Covid

By David Tuller, DrPH McMaster University in Hamilton, Ontario, has launched a clinical trial of the Lightning Process (LP), a well-known “mind-body” intervention, as a treatment f...

Read source
bioengineer.org /1 month ago

Randomized Phase II Trial Tests Nivolumab Then Nivolumab-Ipilimumab or Docetaxel

A new randomized Phase II clinical trial, OPTIM, is testing whether escalating immune therapy can improve outcomes for people with recurrent or metastatic squamous cell carcinoma o...

Read source
rnz.co.nz /2 weeks ago

'The type of treatment we're looking for': Worldwide cancer trial shows promise in treatment of melanoma

Forty-five Kiwi patients have participated among 1000 worldwide, with possible benefits for those with other forms of cancer.

Read source
bioengineer.org /1 month ago

Early Trial Tests Ontorpacept Plus Doxorubicin for Advanced Leiomyosarcoma

A new Phase 1/2 clinical study is testing whether an immune-targeting drug can make chemotherapy more effective against high-grade leiomyosarcoma, an aggressive cancer arising from...

Read source
journals.plos.org /1 month ago

In silico clinical trials of BiTE expression by oncolytic viruses reveal the impact of patient heterogeneity on dosage p...

by Adrianne L. Jenner, Robyn P. Araujo, Noa L. Levi, Guy Ungerechts, Christine E. Engeland, Johannes P. W. Heidbuechel Immunotherapies have become a transformative therapeutic str...

Read source
nbcdfw.com /1 month ago

Dallas clinical trial testing new approach to ALS gives patients & doctors hope

When Sunny Brous was 25, she noticed something strange. The muscles in her hand seemed to twitch, and her hand felt weak. She says the issue became an eye-opener during a co-ed sof...

Read source
theguardian.com /1 month ago

First patients enrolled in record-breaking Ebola treatment trial in DRC

Two drugs are being trialled in the Ituri region in a programme set up just six weeks after the outbreak was declared, with hopes it will reduce mortality ratesThere is no approved...

Read source
fightaging.org /1 month ago

Proposing the Synergy of Therapeutic Plasma Exchange and Partial Epigenetic Reprogramming

It seems a little early in the development of partial epigenetic reprogramming as a class of therapy to be thinking about which of the other approaches to aging it can best be comb...

Read source
wsls.com /1 month ago

An experimental Alzheimer's drug shows some promise as researchers hunt new approaches

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau.

Read source
wcpo.com /1 month ago

An experimental Alzheimer's drug is showing some promise

An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments — by lowering levels of a brain protein called tau, researchers r...

Read source
refractor.io /1 month ago

Antibody treatment halts aggressive prostate cancer in early trials

A newly developed antibody has halted the growth and spread of aggressive prostate cancer in preclinical tests, raising hopes for a more targeted way of treating metastatic disease...

Read source
painnewsnetwork.org /1 month ago

First Successful Treatment of Arachnoditis Published  

By Dr. Forest TennantFor the first time since arachnoiditis was identified and defined in medical dictionaries in 1873, patients and physicians now have a successful peer-reviewed...

Read source
independent.co.uk /1 month ago

New experimental drug shows promise in slowing early Alzheimer’s

An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau

Read source
snacksafely.com /1 month ago

Can Peanut Allergy Be Changed in Infancy? DBV’s THRIVE Trial Tests a Bold New Approach

Researchers are testing whether starting peanut patch therapy in infancy can permanently change the course of peanut allergy. The post Can Peanut Allergy Be Changed in Infancy? DBV...

Read source
multiplesclerosisnewstoday.com /4 weeks ago

FDA OKs first clinical trial testing novel oral therapy in MS patients

Following the submission of thousands of pages of documentation, the U.S. Food and Drug Administration (FDA) has given the green light for a mid-stage clinical trial of Lucid-MS, a...

Read source
drugs.com /2 weeks ago

Chemo-Free Treatment Shows Promise For Some Metastatic Breast Cancer Patients

TUESDAY, Aug. 25, 2026 — A new approach to treating metastatic breast cancer may allow some patients to avoid chemotherapy, at least initially. In a small early-stage trial recentl...

Read source
disabled-world.com /6 days ago

Chemogenetics: Rewriting the Rules of Disability Care

Chemogenetics uses engineered receptors and inert drugs to switch neurons on or off, opening reversible new treatments for epilepsy, pain and paralysis

Read source
ktla.com /1 month ago

Veterans to test GLP-1 drugs as alcohol addiction treatment

The federal government is launching a clinical trial to determine whether a popular class of weight-loss and diabetes medications can help treat alcohol use disorder in veterans. T...

Read source
sciencedaily.com /5 days ago

New injectable treatment helps the brain rebuild after stroke

Duke researchers developed an injectable scaffold that helped stroke-damaged brains grow new blood vessels, support nerve regrowth, and recover movement in mice. The treatment appe...

Read source
multiple-sclerosis-research.org /1 month ago

Treatments (Part 8) Who isn’t using anti-CD20 depleting antibodies?

The MS world is changing and the advent of anti-CD20 depleting antibodies has allowed this to happen. For many years you had to get rid of T cells to control MS and that would give...

Read source
hemophilianewstoday.com /1 month ago

Experimental treatment maintains low bleed rates in hemophilia A

Denecimig (Mim8), an investigational antibody therapy being developed by Novo Nordisk, continued to maintain low bleeding rates in children, adolescents, and adults with hemophilia...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Experimental Treatment

independent.co.uk

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

hemophilianewstoday.com

Recent coverage from public sources
Public source

journals.plos.org

Recent coverage from public sources
Public source

ktla.com

Recent coverage from public sources
Public source

medicalxpress.com

Recent coverage from public sources
Public source